HOME >> MEDICINE >> NEWS
Researchers Identify Candidate Immunosuppressant With Fewer Side Effects

BOSTON-April 22, 1998--Researchers at Harvard Medical School and the Center for Blood Research have identified a peptide that may serve as a template for a drug that can suppress the immune response with fewer side effects than immunosuppressants currently available. In addition to benefiting people who receive organ transplants, a drug based on this agent potentially could be used to treat chronic conditions caused by excessive or inappropriate immune responses, such as asthma, inflammation, allergies, and rheumatoid arthritis. Their findings are published in the April 24 Molecular Cell.

The two main immunosuppressant drugs used today, cyclosporin A and FK506, prevent the rejection of foreign organs or bone marrow by disrupting the signaling pathway that activates T cells. But both drugs can cause kidney and nervous system damage, making them unsuitable for wider clinical application. The newly identified peptide prevents a single, specific step in the immune system's signaling pathway, so researchers anticipate that it will not cause serious side effects.

Anjana Rao, professor of pathology, Patrick Hogan, investigator, and their colleagues at Harvard Medical School and the Center for Blood Research made a peptide that binds to calcineurin, a key molecule in the pathway that transmits signals from the T cell receptor to the nucleus. The key difference between how the peptide and the drugs cyclosporin A and FK506 work is the region on calcineurin where each of these agents bind. Cyclosporin A and FK506 block the active site of calcineurin and prevent it from acting on any other molecules within the cell. The peptide, on the other hand, only blocks specific binding between calcineurin and NFAT (nuclear factor of activated T cells). Other calcineurin functions are unimpeded.

With the peptide in place, calcineurin is unable to bind to the transcription factor NFAT and the signaling pa
'"/>

Contact: Peta Gillyatt
pgillyat@warren.med.harvard.edu
617-432-0443
Harvard Medical School
24-Apr-1998


Page: 1 2

Related medicine news :

1. Researchers search for first sign of congestive heart failure
2. Researchers say breast cancer in Africa may provide clues to the disease in African-Americans
3. Researchers close in on breast cancer vaccine
4. Researchers discover link between insulin and Alzheimers
5. Researchers model brains electrical storm during a seizure
6. Researchers track programs success in curbing aggressive behavior
7. Researchers confirm Vioxx nearly doubled cardiovascular risks in cancer prevention study
8. Researchers offer emergency workers a lifeline
9. Researchers discover genetic variant that may explain why women develop M.S. more than men
10. Researchers map the sexual network of an entire high school
11. Researchers hope monkeys can provide new insights into depression

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/16/2019)... ... August 16, 2019 , ... ... pharmaceutical and non-pharmaceutical cannabidiol (CBD) products across the CBD market in the United ... its crowdfunding campaign to raise $50 million on September 9, 2019. , Established ...
(Date:8/16/2019)... PARK, N.Y. (PRWEB) , ... August 16, 2019 ... ... fabricated, and donated a custom handcrafted, one-of-a-kind children’s aircraft to Ronald McDonald House ... was designed to give children residents undergoing medical treatments and their family members ...
(Date:8/16/2019)... ... August 16, 2019 , ... Dr. Demetri Arnaoutakis, ... esteemed Haute Beauty Network. , The Haute Beauty Network, well known for its ... as a hair restoration expert and our newest addition to the Haute Beauty ...
(Date:8/15/2019)... ... August 15, 2019 , ... ... pathology residents who have been directly affected by the closure of Hahnemann University ... donations gathered during the campaign, the ASCP Foundation will be making hardship grants ...
(Date:8/15/2019)... ... August 15, 2019 , ... Jon ... deadline for family planning clinics to provide written assurance that they will comply ... Similar to the Global Gag Rule, the new policy restricts providers and clinics ...
Breaking Medicine News(10 mins):
(Date:8/15/2019)... ... August 15, 2019 , ... Inc. ... the most prestigious ranking of the nation’s fastest-growing private companies. The list represents ... dynamic segment—its independent small businesses. Microsoft, Dell, Domino’s Pizza, Pandora, Timberland, LinkedIn, Yelp, ...
(Date:8/14/2019)... ... August 14, 2019 , ... Bach ... and development of its drug platform GVT (Monosodium Luminol), created to treat and ... among others. Overwhelming data from multiple animal studies have proven that GVT has ...
(Date:8/14/2019)... ... August 14, 2019 , ... The Memorial Sports Medicine ... athletic trainers for its sports programs. , As part of the agreement, ... , The school currently has eight team sports and nearly 150 athletes ...
Breaking Medicine Technology:
Cached News: